TRDA

Natarajan Sethuraman

Known title: Chief Scientific OfficerCIK: 0001873394

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 27, 2026

TRDA sees institutional interest from NVIDIA and Merck. The Benzinga report notes that institutional investors linked to NVIDIA and Merck have increased their positions in TRDA. This activity signals growing confidence in the company’s pipeline and may attract additional attention from other investors. The move comes as TRDA trades near the lower end of its 52‑week range, providing a potential entry point for those monitoring the stock.

this person other insiders at TRDA

Transaction History

TRDA▼ Sell$15K
TRDA▼ Sell$399K
TRDA▼ Sell$89K
TRDA▼ Sell$45K
TRDA▲ Buy$0
TRDA▼ Sell$10K
TRDA▼ Sell$72K
TRDA▲ Buy$0
TRDA▼ Sell$236K
TRDA▼ Sell$83K
TRDA▼ Sell$2K
TRDA▼ Sell$54K
TRDA▼ Sell$28K
TRDA▼ Sell$53K
TRDA▼ Sell$179K
TRDA▼ Sell$94K
TRDA▼ Sell$13K
TRDA▼ Sell$11K
TRDA▼ Sell$40K
TRDA▼ Sell$9K
TRDA▼ Sell$3K
TRDA▼ Sell$15K
TRDA▼ Sell$3K
TRDA▼ Sell$248
TRDA▼ Sell$7K
TRDA▼ Sell$11K
TRDA▼ Sell$11K
TRDA▼ Sell$147K
TRDA▼ Sell$126K
TRDA▼ Sell$15K
TRDA▼ Sell$18K
TRDA▼ Sell$6K
TRDA▼ Sell$4K
TRDA▲ Buy$0
TRDA▼ Sell$6K
TRDA▲ Buy$0
TRDA▼ Sell$268K
TRDA▼ Sell$54K
TRDA▼ Sell$71K
TRDA▼ Sell$12K
TRDA▲ Buy$0
TRDA▲ Buy$0
TRDA▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.